WO1999041996A1 - Probiotic composition and the use thereof - Google Patents
Probiotic composition and the use thereof Download PDFInfo
- Publication number
- WO1999041996A1 WO1999041996A1 PCT/SE1999/000231 SE9900231W WO9941996A1 WO 1999041996 A1 WO1999041996 A1 WO 1999041996A1 SE 9900231 W SE9900231 W SE 9900231W WO 9941996 A1 WO9941996 A1 WO 9941996A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- feed
- composition according
- fibuliger
- composition
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Definitions
- the present invention relates to a probiotic composition
- a probiotic composition comprising spores from one or more strains of the yeast species Endomyces fibuliger (also named Saccharomyces fibuliger etc.).
- the composition can be used, on one hand, as feed additive to mammals (principally monogastric), avian and fish for improved growth and feed utilisation and, on the other hand, as pharmaceutical/food/feed preparation for human and animals, avian and fish, especially against gastrointestinal disorders.
- the composition can be used to control the intake of food.
- the composition can be used to inhibit putrefaction and mould growth, respectively.
- microorganisms e.g. different lactic acid bacteria
- microorganisms can be added either by fermented products, such as youghurt containing living cells (to human) and grass ensilage (to animals), or in a pure culture as probiotic preparation.
- the microorganisms of the fermented products die during the storage of the product and, therefore, the dose of living organisms becomes low and unreliable.
- the metabolites in the form of e.g. carboxylic acids and enzymes etc. in the fermented product may often be of greater importance for the aspects of food regarding health and assimilation of food than the occurrence of living cells.
- Organisms added shall i.a. suppress the activity of undesired organisms in the process.
- a probiotic product is intended to affect directly the fermentation process of the gastrointestinal tract. It is quite 2
- Appropriate probiotic microorganisms added with the food can i.a. influence the composition of bacteria and, owing to that, i.a. the enzyme activity and the fermentation in the gastrointestinal tract.
- the favourable microorganisms reduce disturbances from pathogenic microorganisms by suppressing the undesired organisms in different ways.
- antibiotics are often added in low doses.
- the problem of resistance development of pathogenic organisms and the transfer of the antibiotic substances into animal foodstuffs makes it very desirable to reduce the use of antibiotics to animals as well as humans.
- most of the known probiotic preparations have had difficulties in competing with antibiotic substances.
- yeast Endomyces fibuliger in a highly vital spore culture as probiotic composition is not previously known.
- This yeast species is known for use in the fermentation of i.a. starch-rich foodstuff raw materials, mostly in certain Asian countries.
- the yeast is known, to a lower extent, for the fermentation of feed and for other specific purposes, e.g. for making use of starch-rich waste in the agricultural processing industry for the manufacture of feed protein in the form of killed yeast (e.g. the "symba" process where organisms of the species Endomyces fibuliger are used to digest the starch contents of the waste to sugar and Saccharomyces cerevisiae is used for the growth of the single cell protein).
- Ci4-Ci s -hydroxy fatty acids which mixture has antimicrobial activity against Vibro trognes but not against any other microorganisms tested.
- yeast for better feed utilisation and as a probiotic.
- a natural product BX-1, since mid 1980th. It is produced by fermenting rice bran with a mixed culture of an originally natural contamination of a number of different organisms, of which Bacillus brevis and a number of different strains of Endomyces fibuliger are predominant.
- the interesting substances of the natural product are chiefly supposed to be residual enzymes of the fermented and dried bran.
- the natural product is used i.a. as feed additive, with good results on meat quality, animal health and feed utilisation.
- the natural product contains a very low number of living microorganisms compared to a highly active culture. The product is added to the animal feed in an admixture of 0.5- 1.0%.
- the product is manufactured by composting rice bran where one intentionally, by using a low exposure to oxygen (meter-high composts) and a long time, seeks to reduce the number of living yeast cells in the fermented product.
- High occurrence of living yeast cells has been considered to be a problem as feed additive and, therefore, the composting process for the manufacture of the natural product has been adjusted so that the yeast is "unfairly treated" during the process.
- a highly vital probiotic microorganism surviving the passage to the gastrointestinal tract and which is only needed in a low dose would be desirable.
- suitable probiotic candidate organism shall have a desired effect e.g. on health condition and the food utilisation, there must be a rational way of distributing the probiotic culture to the gastrointestinal tract. When distributing via dry feed, it is required that the culture manages to survive both the heating when pelleting the feed and the air oxygen during the storage up to consumption. 5
- thermostable withstand high temperatures
- oxygen-stable withstand O 2
- acid-stable withstand high concentrations of hydrogen ions H +
- One problem is the difficulty for the animal producer himself to distribute 1000th part amounts via daily feed processing.
- Industrial premixture in premixes of probiotic preparations in ppm amounts solves the problem of achieving a continuous dosing.
- the other important problem is that many microorganisms do not survive the stomach and therefore do not reach the intestines in a vital condition.
- the object of the present invention is, therefore, to provide a probiotic composition providing reduced incidence of gastrointestinal disorders in humans and animals as well as increased feed conversion and possibility of feed control in animals.
- the invention relates to a probiotic composition
- a probiotic composition comprising spores from a highly vital culture selected from suitable strains of the yeast species Endomyces fibuliger (also named Saccharomyces fibuliger etc.).
- the yeast species used according to the invention is preferably prepared by the solid fermentation method disclosed in Applicant's SE application No. 9800506-9 filed simultaneously and which hereby is included by reference. This method provides ae highly vital spore culture (ascospores) which is thermostable, oxygen-stable and acid-stable.
- Endomyces fibuliger is a harmless yeast species which is commercially available in different oriental starter cultures for the fermentation of starch- rich foodstuffs.
- strain ATCC 2080 Chinese yeast for the preparation of "hoang-chiu”, strain ATCC 24945; "Ragi & Tape” fermentation, strain ATCC 6
- the normal dose of known probiotic cultures is about 500 000- 1 000 000 cfu/g (colony-forming cells per gram) ds (dry substance) feed as prophylaxis.
- a suitable dose of Endomyces fibuliger as prophylaxis is about 5000- 100 000 cfu/g ds feed, e.g. 5 000- 10 000 cfu/g ds feed.
- the invention relates to a composition comprising Endomyces fibuliger as a pharmaceutical preparation.
- the pharmaceutical preparation is mainly intended for treatment of gastrointestinal disorders in humans and animals.
- the composition In prophylactic treatment of animals, the composition is contained in feed and has an activity of Endomyces fibuliger of 5000- 100 000 CFU/g ds feed.
- the composition In therapeutical treatment of gastrointestinal disorders in humans and animals, the composition is administered in a daily dose of 10 7 - 10 13 CFU/individual.
- Endomyces fibuliger does not colonize in the gastrointestinal tract but probably it manages to germinate from the spore and propagate a few times at the passage. It can grow in the intestine but probably slowly. However, for an optimal growth environment much more and easily available oxygen is required. Endomyces fibuliger is, in living form when growing, a very large organism. The typical thing is that it grows to a bush-like collection of yeast cells where the cells, to begin with, are more similar to fungus hyphae than to the form and size of the typical yeast cell. It takes the typical shape of the yeast cell, monocellular and large with an oval-shaped form when the colony grows older at decreasing growth.
- the size and the form may partly explain the low dose requirement owing to the fact that the production of metabolites takes place in a large biomass relative to the number of organisms.
- the yeast spores added to the feed are, however, very small and can be compared to the size order of the bacterium.
- the living yeast Endomyces fibuliger withstands very low pH values for a long time.
- the yeast effectively produces (aerobically as well as unaerobically) 8
- acetic acid and lactic acid Due to the fact that it is a hyper-producer of amylases, these bacteriostatic carboxylic acids are produced directly from a starch substrate. The distribution between the production of acetic acid and lactic acid varies from strain to strain but the amount is often comparable. It is known that a mixture of these acids has a very good bacteriostatic effect.
- the yeast also produces other bacteriostatic carboxylic acids in small amounts as well as smaller amounts of alcohol. The yeast inactivates bacteria but also fungi, in addition to the bacteria which do well in the acidic environment which the yeast establishes quickly. The dosage and nutrient access of the yeast are decisive for the bacteriostatic effect in the intestine during the passage of food in the gastrointestinal tract.
- Endomyces fibuliger is an extreme O 2 -consumer. This, to a certain extent, can contribute to creating favourable conditions for growth of anaerobic lactic acid bacteria. A good establishment of lactic acid bacteria is important for the outer protective function barrier of the mucose.
- Endomyces fibuliger can be used per se or in combination with other organisms known to have probiotic effect in mixed cultures.
- One requirement is that they "do well" together with the yeast.
- Spore cultures of different Bacillus species such as B. cereus, B. subtilis, B. brevis etc., are of particular interest in distribution via dry feed, which cultures withstand heating in feed processing and oxygen exposure during the storage of the feed up to consumption.
- Coated or encapsulated cultures of other medically or probiotically beneficial organisms are also of interest.
- the production of spore cultures of Bacillus species does not require the use of any expensive processing method for coating of the organism in order to withstand heat and the air oxygen.
- Several different strains of Bacillus species are today approved as probiotic feed additives. Together with Endomyces fibuliger there is obtained, with Bacillus strains, a broader spectrum of the enzyme production in the fermentation of the intestine. Observations indicate that a full synergistic effect probably is achieved with 9
- Endomyces fibuliger in monoculture and in co-culture with Bacillus brevis has, in experiments, resulted in a reduced incidence of diarrhoea in swine and an increased feed utilisation.
- the swines' hunger becomes more satisfied and they stop being compulsive eaters with the addition of Endomyces fibuliger in the feed of the invention.
- the animals digest the food for a longer time of the hours of the day.
- a more distributed eating and a longer time for digestion result in a more effective economizing of the food energy.
- a concentrated eating at a few occasions results in that the animals have to cool-off the heat excess when the larger amount of food per eating occasion is digested. Then, the animal body is forced to consume energy from the body reserve (resulting in further losses) when the digestion of food moves "into a low gear" before the next eating occasion.
- the eating behaviour seems to change so that the pigs eat less on each occasion and eat on several occasions.
- the feeding of swines takes place on three occasions per day.
- the eating takes place under great competition within the litter, where the strongest ones eat more at the expense of the weaker individuals.
- the changed eating behaviour gives rise to two effects.
- the one effect is that the daily consumption per pig decreases at the same time as growth increases.
- the other effect is that the competition 10
- the effect of Endomyces fibuliger as feed additive is, on one hand, to be probiotic with a reduced incidence of diarrhoea and, on the other hand, to influence the decomposition process of the feed favourably with regard to the utilisation of the nutrient of the food with regard to energy as well as protein.
- Example 1 Dysentery in pigs treated with high doses of Endomyces fibuliger
- Example 2 Diarrhoea in pigs treated with high doses of Endomyces fibuliger
- Example 3 Prophylactic treatment against diarrhoea in pigs with a low dose of Endomyces fibuliger
- Example 4 The growth of pigs is influenced by a high dose of Endomyces fibuliger
- Example 5 Feed control with Endomyces fibuliger, specific dose (kind of animal, age, sex)
- Example 6 Indigestions in humans treated with Endomyces fibuliger in high dose
- Nutritive substrate in the form of starch-rich foodstuff products were infected with microorganisms from excrements, rumen liquid etc., natural flora in stored cereals etc., with and without the presence of Endomyces fibuliger.
- Endomyces fibuliger With the addition of Endomyces fibuliger, similar results were obtained in all cases, that is, the process of putrefaction ceases or is suppressed very rapidly and effectively, even at good oxygen supply to the substrate.
- the yeast species Endomyces fibuliger immediately takes control over the fermentation and the typical odour of putrefaction disappeared or was reduced drasticly in aerobic environment as well as in anaerobic environment. This aspect of the invention is useful for e.g. reducing putrefaction of manure in basins and compost.
- This aspect of the invention is useful for e.g. preserving foodstuffs and cereals.
- Fig. 1 shows the consumption in kg feed per kg weight gain live weight (FCR
- Fig. 4 shows the number of test days in respective experiments
- Fig. 5 shows a summary of Fig. 1-4 i tabular form
- Fig. 6 shows live weight at onset and termination, respectively, for each experiment.
- Example 11a Weight gain per kg feed (FCR) in slaughter swines treated with Endomyces fibuliger and Bacillus brevis (Fig. 1-6, trial No. 2)
- a group consisting of 82 slaughter swines was treated by addition to the feed of a culture comprising spores, on one hand, from the species Endomyces fibuliger, dose 5000 cfu/g feed (dw), and, on the other hand, from the species Bacillus brevis, dose 2000 cfu/g feed (dw).
- the control consisted of 83 pigs.
- the feed consumption decreased from 3.35 kg feed/kg growth to just below 2.98 kg feed/kg growth (live weight, lw) for a 20 days test period (Fig. 4).
- the slaugther swines in the treated group ate 4.9% less feed per day (Fig. 3) and 17
- Example l ib and c Weight gain per kg feed (FCR) in slaughter swines treated with Endomyces fibuliger (Fig. 1-6, trials Nos. 3 and 4)
- the feed was provided with only yeast spores of the species Endomyces fibuliger, dose 5000 cfu/g feed (dw).
- a restrictive ration was given with the same amount of feed per day to both the control and the treated group; in trial 4 feed was provided ad libitum up to about 65 kg live weight.
- Example l id Weight gain per kg feed (FCR) in piglets treated with Endomyces fibuliger (Fig. 1-6, trial 5)
- Example 12 Improvement in FCR and reduction of the number of feeding days in slaughter swines treated with the addition of a low dose of Endomyces fibuliger in feed
- the feeding experiments show an essential improvement of feed conversion and daily growth and a small but important reduction of the daily feed intake when Endomyces fibuliger, with or without Bacillus brevis, is added to the feed.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99934234A EP1056354A1 (en) | 1998-02-20 | 1999-02-19 | Probiotic composition and the use thereof |
CA002321275A CA2321275A1 (en) | 1998-02-20 | 1999-02-19 | Probiotic composition and the use thereof |
AU32832/99A AU3283299A (en) | 1998-02-20 | 1999-02-19 | Probiotic composition and the use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800505A SE9800505L (en) | 1998-02-20 | 1998-02-20 | Probiotic composition containing spores from the yeast species Endomyces fibuliger and its use |
SE9800505-1 | 1998-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999041996A1 true WO1999041996A1 (en) | 1999-08-26 |
Family
ID=20410242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1999/000231 WO1999041996A1 (en) | 1998-02-20 | 1999-02-19 | Probiotic composition and the use thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1056354A1 (en) |
AU (1) | AU3283299A (en) |
CA (1) | CA2321275A1 (en) |
SE (1) | SE9800505L (en) |
WO (1) | WO1999041996A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2810337A1 (en) * | 2000-06-20 | 2001-12-21 | Univ Clermont Auvergne | New microorganisms expressing heterologous gene, useful e.g. for detoxification, have high survival rates in stomach and colon |
EP1314359A1 (en) * | 2001-11-21 | 2003-05-28 | N.V. Seghers Nutrition Sciences | Growth promoter composition for animals |
US8519008B2 (en) | 2003-01-22 | 2013-08-27 | Purina Animal Nutrition Llc | Method and composition for improving the health of young monogastric mammals |
CN106509342A (en) * | 2016-09-26 | 2017-03-22 | 广州好师傅生物科技有限公司 | Feed additive capable of replacing antibiotics and preparation method thereof |
CN116832070A (en) * | 2023-06-21 | 2023-10-03 | 南京大学 | Application of saccharomycetes curvularia in preparing medicines for treating and/or improving non-alcoholic fatty liver disease |
-
1998
- 1998-02-20 SE SE9800505A patent/SE9800505L/en not_active IP Right Cessation
-
1999
- 1999-02-19 AU AU32832/99A patent/AU3283299A/en not_active Abandoned
- 1999-02-19 WO PCT/SE1999/000231 patent/WO1999041996A1/en not_active Application Discontinuation
- 1999-02-19 CA CA002321275A patent/CA2321275A1/en not_active Abandoned
- 1999-02-19 EP EP99934234A patent/EP1056354A1/en not_active Ceased
Non-Patent Citations (4)
Title |
---|
DIALOG INFORMATION SERVICES, File 155, MEDLINE, Dialog Accession No. 07658723, Medline Accession No. 94029535, KMET V. et al., "Probiotics and Manipulation of Rumen Development and Function"; & ARCH. TIERERNAHR., 1993, 44(1), p. 1-10. * |
DIALOG INFORMATION SERVICES, File 351, DERWENT WPI, Dialog Accession No. 003233765, WPI Accession No. 81-94323D/198151, AS LATV MICROBIOL., "Fodder Additive Contg. Cellulase and Glucoamylase Enzymes - Prepd. by Jointly Cultivating Specified Strains of Fungus Trichoderma Lignorum and Yeast Endomycopsis * |
FILE WPI, Derwent Accession No. 82-69779E, AS LATV MICROBIOL., "Animal Feed Microbial Additive - Contg. Endomicopsis Fibuliger R-574 Yeast Strain Biomass for Glucoamylase and Cellulase Enzymic Activity"; & SU,A,874 022 (25-10-81). * |
FILE WPI, Derwent Accession No. 85-268607, BIOTECHN. RES. INST., "Yeast Strain Endomycopsis Fibuliger C-4 - is Used as Producer of Feedstuff Protein"; & SU,A,1 150 264 (15-04-85). * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2810337A1 (en) * | 2000-06-20 | 2001-12-21 | Univ Clermont Auvergne | New microorganisms expressing heterologous gene, useful e.g. for detoxification, have high survival rates in stomach and colon |
WO2001098461A1 (en) * | 2000-06-20 | 2001-12-27 | Universite D'auvergne | Micro-organisms active in the digestive environment |
EP1314359A1 (en) * | 2001-11-21 | 2003-05-28 | N.V. Seghers Nutrition Sciences | Growth promoter composition for animals |
WO2003043440A2 (en) * | 2001-11-21 | 2003-05-30 | Nutrition Sciences N.V. | Growth promoter composition for animals |
WO2003043440A3 (en) * | 2001-11-21 | 2003-12-18 | Nutrition Sciences Nv | Growth promoter composition for animals |
US9078457B2 (en) | 2003-01-22 | 2015-07-14 | Purina Animal Nutrition Llc | Method and composition for improving the health of young monogastric mammals |
US8519008B2 (en) | 2003-01-22 | 2013-08-27 | Purina Animal Nutrition Llc | Method and composition for improving the health of young monogastric mammals |
US9433232B2 (en) | 2003-01-22 | 2016-09-06 | Purina Animal Nutrition Llc | Methods for feeding sows and for improving the health of young piglets |
US10172376B2 (en) | 2003-01-22 | 2019-01-08 | Purina Animal Nutrition Llc | Methods for feeding sows and for improving the health of young piglets |
US10980250B2 (en) | 2003-01-22 | 2021-04-20 | Purina Animal Nutrition Llc | Methods for feeding sows and for improving the health of young piglets |
US11452303B2 (en) | 2003-01-22 | 2022-09-27 | Purina Animal Nutrition Llc | Methods for feeding sows and for improving the health of young piglets |
CN106509342A (en) * | 2016-09-26 | 2017-03-22 | 广州好师傅生物科技有限公司 | Feed additive capable of replacing antibiotics and preparation method thereof |
CN116832070A (en) * | 2023-06-21 | 2023-10-03 | 南京大学 | Application of saccharomycetes curvularia in preparing medicines for treating and/or improving non-alcoholic fatty liver disease |
Also Published As
Publication number | Publication date |
---|---|
SE510505C2 (en) | 1999-05-31 |
AU3283299A (en) | 1999-09-06 |
SE9800505D0 (en) | 1998-02-20 |
EP1056354A1 (en) | 2000-12-06 |
SE9800505L (en) | 1999-05-31 |
CA2321275A1 (en) | 1999-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Geary et al. | Effect on weaner pig performance and diet microbiology of feeding a liquid diet acidified to pH 4 with either lactic acid or through fermentation with Pediococcus acidilactici | |
CN110122658A (en) | A kind of fermentative feedstuff of microbe and its preparation method and application | |
KR102255611B1 (en) | Method for preparing fermented total mixed ration using microbial strain complex | |
CN106962609A (en) | A kind of direct putting type biological fermentation feed additive and its production and use | |
CN102204632A (en) | Microbial feed additive for increasing livestock and poultry product quality and improving meat egg milk flavor and preparation method thereof | |
CN109601699A (en) | A kind of functional microbial fermented feed and production method and application | |
CN101209088A (en) | Microorganism polyzyme additive agent for improving pigling growth and development | |
WO1994011492A1 (en) | Method of favorably modifying poultry intestinal microflora | |
CN102379374A (en) | Microbial high-activity preparation, high-activity microbial protein forage and preparation method thereof | |
CN110463843A (en) | The corncob bacterium enzyme cooperative fermentation feed and its production technology for being suitble to growing and fattening pigs feeding | |
CN112471353A (en) | Long-acting symbiotic composite liquid microecological preparation for poultry feeding and preparation method thereof | |
KR100876521B1 (en) | A probiotics for fermenting mixed rations and a method for fermenting the mixed rations using the probiotics | |
CN101219154A (en) | Microorganism additive agent for improving phylactic power of pets and accelerating growth | |
KR102492755B1 (en) | Method for preparing fermented total mixed ration using microbial strain complex and steam treatment | |
KR101115306B1 (en) | Method of preparing jujube probiotics using solid-state fermentation for livestocks and use of it | |
CN113414226A (en) | Kitchen waste leavening agent and preparation method and application thereof | |
EP0971032A1 (en) | Growth promoting material for useful microorganisms and process for producing the same | |
CN102334602A (en) | Preparation method of bioactive composite high-efficiency feed nutrient solution used for livestock and poultry | |
KR100688441B1 (en) | Feed additive using citrus peel and method for manufacturing thereof | |
WO1999041996A1 (en) | Probiotic composition and the use thereof | |
KR20010103114A (en) | The method for manufacturing of microorganism annex contain feed | |
CN108669295A (en) | A kind of corn feed | |
CN114376093A (en) | Bacterium-enzyme synergistic fermented feed suitable for sows and preparation method thereof | |
KR20020024197A (en) | High functional fermented starch products prepared by order-fermentation of microorganisms and preparation thereof | |
CN116058434A (en) | Composite microbial agent rapid-fermentation feed and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
ENP | Entry into the national phase |
Ref document number: 2321275 Country of ref document: CA Ref country code: CA Ref document number: 2321275 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999934234 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09622446 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999934234 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWR | Wipo information: refused in national office |
Ref document number: 1999934234 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999934234 Country of ref document: EP |